The QualityStocks Daily Friday, January 19th, 2024

Today's Top 3 Investment Newsletters

QualityStocks(ILUS) $0.0160 +90.48%

360 Wall Street(MESA) $0.9600 +49.98%

INO Market Report(BFRG) $4.8900 +25.71%

The QualityStocks Daily Stock List

Ilustrato Pictures International (ILUS)

QualityStocks, NetworkNewsWire, Small Cap Firm, OTCtipReporter, Penny Pick Finders, StockOnion, PennyStockScholar, PennyStockProphet, Profitable Trader Authority, Planet Penny Stocks, Buzz Stocks, StocksToBuyNow, StockRockandRoll, Real Pennies, Penny Stock Titans,, Equity Observer, Fortune Stock Alerts, MarketClub Analysis, Jet-Life Penny Stocks, Penny Stock General, Shiznit Stocks, StockHideout, PennyPickAlerts, SmallCapGrowth, Beacon Equity Research, Value Penny Stocks, Trades Of The Day, SuperStockTips, GrowthPennyStocks, InvestorSoup, StockRunway, Journal Transcript, Stock Preacher, SmallCapVoice, ProTrader, Penny Stock 101, Penny Stock 103, Penny Stock Craze, Penny Stock Finder, Penny Stock Prodigy, SeriousTraders, Awesome Stock Tips, RockingPennyStocks, Whisper from Wall Street and Otcstockexchange reported earlier on Ilustrato Pictures International (ILUS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Ilustrato Pictures International Inc. (OTC: ILUS) is a mergers and acquisitions investment firm that is engaged in the acquisition of businesses in the manufacturing, engineering and technology sectors globally.

The company operates out of Dubai, London and New York and is based in London, the United Kingdom. It was incorporated in 2010, on April 27th and mainly operates in Hong Kong, the People’s Republic of China.

The company focuses on growing shareholder value by growth and innovation and centers on acquiring businesses that have the potential to grow rapidly and have strong management. The companies acquired will benefit from the cross-pollination of skills, products and territories of other group firms.

Its business includes TVC (The Vehicle Converters LLC), FireBug, FB Technologies and E-Raptor. TVC is engaged in designing and converting vehicles for specialist applications, which include medical ambulances and mobile hospitals. FireBug are manufacturers of firefighting equipment while FB Technologies develops and manufactures specialist equipment and technology for mission-critical companies and emergency services. On the other hand, E-Raptor has been designed to carry heavy workloads as needed by agricultural and industrial users. The firm also develops feature theatrical films for international release. These films are usually financed and distributed in China by Chinese firms engaged in production.

The company recently acquired Bright Concepts Detection & Protection LLC (BCD), which will enable ILUS to conduct direct installation and maintenance of their fixed fire suppression systems in the Middle East. This will also allow the company to keep a bigger share of profit margins while also giving them a platform to market their other products to BCD consumers. This will grow annual revenues while reducing the cost of acquiring new consumers in the region, and this will ultimately be beneficial to both investors and shareholders.

Ilustrato Pictures International (ILUS), closed Friday's trading session at $0.016, up 90.4762%, on 27,414,289 volume. The average volume for the last 3 months is 1,135 and the stock's 52-week low/high is $0.005/$0.0874.

West Texas Resources (WTXR)

SmallCapVoice and MoneyTV reported earlier on West Texas Resources (WTXR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

West Texas Resources Inc. (OTC: WTXR) is an oil and gas exploration and development firm focused on acquiring, exploring for and developing oil and gas properties in North America.

The firm has its headquarters in Frisco, Texas and was incorporated in 2010, on December 9th by Gary E. Bryant. Prior to its name change in June 2011, the firm was known as Texas Resources Energy Inc. It operates as part of the oil and gas E&P industry, under the energy sector. The firm serves consumers in North America.

The company’s objective is to become an independent energy company engaged in the acquisition, development, and exploitation of oil and gas properties in North America in partnership with oil and gas producers. Its strategy is to pursue strategic acquisitions of interests in oil and gas properties, including prospects with proven and unproven reserves, which it believes to have development potential. The company targets both new and existing fields and producing wells to be revitalized.

The enterprise holds a 50% working interest in non-operating leases that cover roughly 1,070 gross mineral acre leases in a property located in Hale County, Texas; 25% working interest in an East Texas oil and gas property; 25% working interest in oil and gas properties located in Gregg County, Texas; and 1% working interest in an oil prospect located in Floyd County, Texas. It also holds a 100% interest in Kiowa properties located in Florida, North Dakota, Kentucky, and Illinois.

The firm remains committed to advancing exploration efforts at its properties and creating additional value for its shareholders.

West Texas Resources (WTXR), closed Friday's trading session at $0.0999, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.075/$0.35.

Reelcause (RCIT)

PennyPickAlerts, Fortune Stock Alerts, TheNextBigTrade, SmallCapVoice, PHUB News, MarketWireStocks, Fabulous Penny Stocks, DSR News, Center Stage Stocks and BestDamnPennyStocks reported earlier on Reelcause (RCIT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Reelcause Inc. (OTC: RCIT) is a company trying to enter the global market through innovative green hydrogen production technology and hydrogen drones based on technology, hydrogen vehicle charging business, and zero-energy buildings based on hydrogen heat-combined power plants.

The firm has its headquarters in Las Vegas, Nevada and was incorporated in 1990 by Jian Liang Shi. Prior to its name change in December 2014, the firm was known as China Green Industries Inc. It operates as part of the specialty industrial machinery industry, under the industrials sector. The firm serves consumers around the globe, with a focus on those in the United States.

The company, through cooperation agreements for small wind power generation based on new and renewable energy technology, plans to develop eco-friendly new and renewable energy technology based on green hydrogen energy of the water electrolysis method.

The enterprise’s target products include Hydrogen Energy, Hydrogen Drone, Small Wind Power and Smart Farm. It is currently focused on commercializing patented technology related to renewable energy projects. The patents are for a product that produces energy using water. The product, which is currently under R&D, is the P2G (Power to Gas) System. This system generates power using a hydrolysis chamber (H2 100% + H2O = hydrolysis chamber). Turbine power generation is CO2-free, meaning it does not emit any greenhouse gases. The enterprise offers its services across various sectors, such as agriculture and aerial technology.

The firm remains focused on contributing to the development of new alternative energy rather than passively addressing global climate and environmental issues in partnership with various organizations.

Reelcause (RCIT), closed Friday's trading session at $0.0187, off by 23.0453%, on 1,000 volume. The average volume for the last 3 months is 3,430 and the stock's 52-week low/high is $0.0043/$0.038.

African Energy Metals (NDENF)

We reported earlier on African Energy Metals (NDENF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

African Energy Metals Inc. (OTC: NDENF) (CVE: CUCO) (FRA: BC20) is a natural resource firm focused on acquiring, developing and exploring mineral properties in the Democratic Republic of Congo.

The firm has its headquarters in Vancouver, Canada and was incorporated in 2007, on March 27th. Prior to its name change in February 2022, the firm was known as Central African Gold Inc. It operates as part of the other industrial metals and mining industry, under the basic materials sector. The firm serves consumers across the globe.

The company primarily explores for lithium, tin, tantalum, rare earths, uranium, silver, and copper metals. It is implementing a carbon credit program complementary to mining operations. The company also focuses on acquiring interests in additional concessions or relinquishing concessions in the normal course of business.

The enterprise holds interests in the Manono Project, which covers an area of 30km² located in Manono region; and the Falea project, which is located in Mali, West Africa. It also holds 200kms² of concessions located in the Kalehe Territory in South Kivu. This territory has high prospectivity for tungsten, cassiterite (tin), lithium, coltan, gold, beryllium, and rare earths. The Kivu region is the same district as the world-class Aphamin tin mine. All of the enterprise’s assets are located in Canada and in the Democratic Republic of Congo.

The firm recently commenced trading under the CUCO symbol on the TSX Venture Exchange, a move that may open it up to new growth and investment opportunities and help generate additional value for its shareholders.

African Energy Metals (NDENF), closed Friday's trading session at $0.0197, even for the day. The average volume for the last 3 months is 36,501 and the stock's 52-week low/high is $0.0145/$0.2556.

Barksdale Resources (BRKCF)

We reported earlier on Barksdale Resources (BRKCF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Barksdale Resources Corp. (OTCQX: BRKCF) (CVE: BRO) (FRA: 2NZ) is a base metal exploration firm focused on acquiring and exploring for highly prospective precious and base metal mineral properties in Mexico and the United States.

The firm has its headquarters in Vancouver, Canada and was incorporated in 1981, on January 13th. Prior to its name change in February 2020, the firm was known as Barksdale Capital Corporation. It operates as part of the other industrial metals and mining industry, under the basic materials sector. The firm mainly serves consumers in Canada.

The enterprise primarily explores for copper, zinc, lead, silver, and gold ores. Its primary asset is the Sunnyside copper-zinc-lead-silver property, which is made up of 286 unpatented mining claims covering about 5,223.71 acres located in the Patagonia Mountains of southern Arizona. This project covers approximately 21km2. It also holds interest in the San Antonio copper-gold project in central Sonora, Mexico. The San Antonio project is in the Patagonia Mountains of southern Arizona and covers more than 25.5km2. In addition to this, the company holds interests in the Four Metals, the Canelo, and the Goat Canyon projects. The Four Metals project is an approximately 760-acre property while the Canelo project comprises of about 433 federal mining claims that cover 8,700 acres. On the other hand, the Goat Canyon project is made up of 430 federal mining claims that cover over 8,650 acres in Santa Cruz County, Arizona.

The company recently gave an update on its drilling operations at its Sunnyside project, with its CEO revealing that they had entered the targeted Paleozoic carbonate sequence, which is the host for copper-zinc-lead-silver CRD mineralization. Successful exploration efforts may encourage additional investments into the company and generate value for its shareholders.

Barksdale Resources (BRKCF), closed Friday's trading session at $0.2538, up 3.6765%, on 27,000 volume. The average volume for the last 3 months is 170 and the stock's 52-week low/high is $0.2448/$0.70.

Iluka Resources (ILKAF)

We reported earlier on Iluka Resources (ILKAF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Iluka Resources Limited (OTC: ILKAF) (ASX: ILU) (FRA: ILZ) is a company focused on exploring, project development, mining, processing, marketing and rehabilitation of mineral sands.

The firm has its headquarters in Perth, Australia and was incorporated in 1954, on July 24th. Prior to its name change in May 1999, the firm was known as Westralian Sands Ltd. It operates as part of the other industrial metals and mining industry, under the basic materials sector. The firm serves consumers around the world.

The company operates through Jacinth-Ambrosia/Mid-West, Rare Earths, Cataby/South West, and United States/Murray Basin segments. Its Jacinth-Ambrosia/Mid-West segment comprises the mining operations at Jacinth-Ambrosia located in South Australia, and associated processing operations at the Narngulu mineral separation plant in mid-west Western Australia. Its Rare Earths segment comprises the Eneabba Rare Earths Refinery that is being constructed in Western Australia. The company’s Cataby/South West segment comprises mining activities at Cataby and processing of ilmenite at Synthetic Rutile Kilns 1 and 2, located in Western Australia. The United States/Murray Basin segment focuses on rehabilitation obligations in Virginia and Florida, and certain idle assets located in Australia.

The enterprise produces titanium dioxide products of rutile and synthetic rutile; zircon; and ilmenite, as well as activated carbon, gypsum, and iron concentrate products. It is also involved in the exploration of rare earths elements, such as xenotime and monazite. Its products are used in construction, technology, lifestyle, medical, defense, and industrial applications.

The firm is well-positioned for growth as the world moves towards a safer, smarter, and more sustainable future and the demand for its high-quality Australian critical minerals products increases.

Iluka Resources (ILKAF), closed Friday's trading session at $4.5, off by 0.662252%, on 331 volume. The average volume for the last 3 months is 3.488M and the stock's 52-week low/high is $4.32/$8.16.

HIVE Blockchain Technologies Ltd. (HIVE)

QualityStocks, MarketClub Analysis, InvestorPlace, MarketBeat, StreetInsider, Zacks, CryptoCurrencyWire, Early Bird,, StockMarketWatch, Stock Market Watch, Greenbackers, Hit and Run Candle Sticks, Barchart, smartOTC, StockOodles, StreetAuthority Daily, The Night Owl, The Online Investor, TopStockAnalysts, Wall Street Resources, WealthMakers and Schaeffer's reported earlier on HIVE Blockchain Technologies Ltd. (HIVE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bitcoin ETFs listed on U.S. exchanges witnessed a trading volume of more than $4.5 billion on Jan. 10, 2024, a day after the U.S. Securities and Exchange Commission (SEC) approved several Bitcoin spot ETFs, according to data from LSEG. The new products signify a crucial moment for the crypto industry, challenging the prevailing perception of digital assets as risky and exploring their potential as mainstream investments.

The long-awaited approval from the SEC arrived last week, concluding a long battle with the crypto sector. The commission had consistently rejected all Bitcoin spot ETFs on claims of investor safety. SEC chair Gary Gensler stated that the approvals did not amount to Bitcoin endorsement, characterizing it as a volatile and speculative asset.

Several company leaders expressed reservations about Bitcoin’s high-risk nature, with major players such as Vanguard, the largest mutual fund provider, stating they did not intend to offer the new Bitcoin spot ETFs to their clients.

The debut of the spot ETF caused Bitcoin’s price to rise to its highest point —$46,303— since 2021. Ether was trading at $2,598.

The regulatory approval sparked a furious battle among issuers for dominance of the market, leading some companies to significantly lower the costs associated with the Bitcoin ETFs even prior to their launch. Currently, fees range between 0.2% and 1.5%, with most even willing to waive the charges for a predetermined period or asset volume. Following the ETF’s launch, Valkyrie waived its fees for three months and also reduced those fees to 0.25%.

Grayscale was granted permission to convert its existing BTC trust into an ETF, making the company’s Bitcoin ETF the biggest in the world with assets valued at more than $28 billion.

Opinions regarding the potential earnings of the new products vary. Analysts at Standard Chartered believe they might get as much as $100 billion in revenue in 2024, although Bernstein predicts flows will progressively rise to $10 billion this year. Others estimate that inflows might reach $55 billion over a five-year period.

A few analysts cautioned that it might be premature to rejoice over the decision. The wider financial community still views cryptocurrencies as dangerous investments, and recent events such as the demise of the cryptocurrency exchange FTX have further increased investor caution. Others, on the other hand, think that the products might pave the way for even more innovative exchange-traded funds for cryptocurrencies, including spot ether products.

If the gold ETFs perform well over the medium- and long-term, they are likely to lift the general crypto industry as well, helping stocks of entities such as HIVE Blockchain Technologies Ltd. (NASDAQ: HIVE) (TSX.V: HIVE) to rise higher as the sentiment toward crypto improves in the wake of the recent shocks the industry suffered.

HIVE Blockchain Technologies Ltd. (HIVE), closed Friday's trading session at $3.18, up 0.315457%, on 3,045,174 volume. The average volume for the last 3 months is 344,270 and the stock's 52-week low/high is $2.20/$6.84.

Verano Holdings Corp. (VRNOF)

QualityStocks, MarketBeat, InvestorPlace, The Street and Early Bird reported earlier on Verano Holdings Corp. (VRNOF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Last year saw many regulated recreational cannabis markets record significant growth in their sales. While established markets such as Colorado recorded slight declines in sales, states such as Maine and Arizona saw growth in their markets. Below, we examine adult-use sales using data from regulators in different states.


Recreational sales started strong last year, with monthly recreational cannabis sales peaking in March at $100 million. The state launched its adult-use cannabis market in 2021.

Washington State

Adult-use cannabis sales in the state have relaxed since the pandemic, with the state selling only $1.14 billion in recreational cannabis through November last year. The figure is a slight decrease from the $1.18 billion recorded in 2022 for the same period.


Despite its record-breaking sales during the pandemic, the marijuana market in California has seen sales slip from late 2021. Between 2021 and 2022, year-over-year sales dropped by more than 10%. In 2023, this figure reduced to 8%, which is promising but still doesn’t represent true recovery.


The state, which outsells California when it comes to adult-use cannabis, didn’t record any significant decline in its growth last year. Figures show that year-over-year sales dropped to 48% between 2022 and 2023, from 55% in 2021 to 2022. It is expected that recreational sales will be strong in 2024.


Decreasing year-over-year marijuana sales over the last two years brought Colorado’s market value to its prepandemic levels. Figures show that between January and October 2023, recreational marijuana sales reached $1.15 billion. This is slightly lower than the figures recorded over the same period in 2019.


Last year, the state’s recreational sales totaled $901 million. This is quite a drop, especially when compared to sales in 2020 and 2021, which surpassed $1 billion. It is expected that adult-use sales in Oregon may recover this year.


The state’s first year of adult-use sales brought in almost $131 million, with forecasts expecting it to reach $145 million.


Last year, the state’s new recreational marijuana market raked in $331 million. Its location on the East Coast and its population density make it a market to watch this year.


Despite the state’s recreational marijuana market hitting new highs in sales last year, its growth has begun to slow. While this is expected in new markets, its decline is a bit more extreme.

Rhode Island

In 2023, the state brought in $74 million in total recreational cannabis sales. This figure is significantly higher than its sales projection of $50 million. Rhode Island’s market is expected to continue growing in 2024.

These successes registered at state level could be because consumers are taking to the legally produced cannabis products made by numerous enterprises such as Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) and other state-legal cannabis businesses.

Verano Holdings Corp. (VRNOF), closed Friday's trading session at $5.16, up 6.5015%, on 656,427 volume. The average volume for the last 3 months is 57.067M and the stock's 52-week low/high is $2.53/$5.56.

NIO Inc. (NIO)

Green Car Stocks, InvestorPlace, Schaeffer's, MarketClub Analysis, The Street, MarketBeat, StocksEarning, QualityStocks, Daily Trade Alert, Trades Of The Day, Kiplinger Today, The Online Investor, StockEarnings, INO Market Report, Zacks, Early Bird, StreetInsider, StockMarketWatch, BUYINS.NET, Cabot Wealth, FreeRealTime, TipRanks, Wealth Insider Alert, GreenCarStocks, InvestorsUnderground, Money Wealth Matters, The Wealth Report, CNBC Breaking News, AllPennyStocks, Daily Wealth, wyatt research newsletter, TradersPro, Investopedia, Energy and Capital, Green Energy Stocks, CRWEWallStreet, InvestorIntel, Investors Alley, InvestorsObserver Team, MarketClub, Louis Navellier, TopPennyStockMovers, Wealth Daily, Smartmoneytrading, Stock Market Watch, The Night Owl, Top Pros' Top Picks, Top Pros’ Top Picks and Jim Cramer reported earlier on NIO Inc. (NIO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

After various legacy automakers announced plans to scale back their previously ambitious electrification plans, car-rental giant Hertz has revealed that it is also selling off a portion of its EV fleet. The Florida-based car-rental company has revealed that it will sell one-third of the electric cars in its EV fleet (around 20,000 battery electric cars) and invest funds in internal combustion engine (ICE) cars.

Even though electric cars theoretically cost less to maintain compared to fossil-fuel-powered cars, Hertz executives noted in a recent executive call that EVs have been harming the company’s bottom lines. This is primarily because electric cars have higher repair costs and depreciate faster than other types of vehicles.

Company CEO Stephen Scherr said that repairing damaged electric cars can cost up to twice as much as the cost of repairing similar gas-powered vehicles. Furthermore, declining vehicle prices in the new electric vehicle market have reduced the resale value of the used cars in Hertz’s electric car fleet.

Increasing competition in China, currently the largest electric-vehicle market in the world, has forced major automakers such as Tesla to cut prices in a bid to remain competitive. The influx of cheap Chinese electric cars into foreign markets has also forced Western automakers to offer their EVs at lower prices. With overall demand for electric cars in major markets such as the United States declining, prices for used electric cars have plummeted.

For Hertz, a fleet company with tens of thousands of electric cars, high repair costs coupled with declining resale costs likely made electric cars seem like an increasingly bad investment. According to Scherr, Tesla-driven price declines last year reduced the resale value of Hertz EVs to below 2023 levels and lowered the company’s chances of salvaging its EV investment.

A Hertz SEC filing revealed that the company expects to lose around $245 million due to electric vehicle depreciation at around $12,250 per EV.

Unsurprisingly, electric vehicle giant Tesla supplied the majority (80%) of the vehicles in Hertz’s electric vehicle fleet. Although Hertz didn’t point fingers in its statement, it is clear that Tesla is largely responsible for Hertz’s decision to offload a third of its electric vehicles.

Facing increasing pressure from local companies such as BYD in the Chinese market, Tesla has engaged in several aggressive price cuts and essentially lowered the value of the used-EV industry. Hertz executives also noted that repairing damaged Teslas is costly and time consuming because Tesla doesn’t have a lot of trained car repair technicians or replacement parts as do other established automakers.

Hertz’s sell-off does not bode well for the electric vehicle industry and could lead to other car rental companies offloading their electric vehicles and turning back to internal combustion engine cars.

Fleet operators have always been seen as key to helping to deepen the uptake of electric vehicles in major markets around the world. Hertz’s decision to downsize its EV fleet sends manufacturers such as NIO Inc. (NYSE: NIO) back to the drawing board to come up with strategies to counter the setback that the step announced by Hertz presents.

NIO Inc. (NIO), closed Friday's trading session at $6.06, off by 3.5032%, on 82,433,119 volume. The average volume for the last 3 months is 582,668 and the stock's 52-week low/high is $5.86/$16.18.

Mind Medicine Inc. (MNMD)

QualityStocks, InvestorPlace, Schaeffer's, MarketBeat, The Wealth Report, The Street, The Stock Dork, MarketClub Analysis, Daily Trade Alert, Wealth Daily and Trades Of The Day reported earlier on Mind Medicine Inc. (MNMD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The state of New Jersey may soon legalize the recreational and therapeutic use of psilocybin mushrooms, following the reintroduction of a measure that was withdrawn in 2023 for revision. The measure, called the Psilocybin Behavioral Health Access and Services Act, concentrates on mental health.

Psilocybin is a naturally occurring psychedelic compound found in hallucinogenic mushrooms. According to research, this compound is metabolized in the body to psilocyn and can penetrate the central nervous system.

The measure was tabled at the state Senate again last week and has strong support, particularly from Senate President Nick Scutari, who originally sponsored the recreational measure that legalized marijuana in New Jersey. If passed, it would establish a legal framework for the sale and manufacture of products that contain psilocybin.

It would also expunge pending and past offenses involving psilocybin while also decriminalizing the drug’s recreational use for individuals aged 21 years and above. If approved, individuals could use, inhale, ingest, store, possess, process and transport no more than four grams of psilocybin. Additionally, residents in the state would be permitted to cultivate magic shrooms for personal use.

The measure’s retabling comes as Hackensack Meridian, a major healthcare provider in the state, plans to administer hallucinogens as a medication for several disorders, among them depression. The company recently announced that it had partnered with Compass Pathways to study the company’s COMP360 psilocybin formulation.

Hackensack CEO Robert Garrett stated that this partnership may lead to trials and, in due time, create tangible change for individuals suffering from a range of mental-health ailments. The company’s senior VP for behavioral health, Kenneth Esser, also highlighted that Hackensack’s research wasn’t impacted by whether the aforementioned measure was approved, as clinical trials were overseen by the U.S. Food and Drug Administration (FDA). The FDA allows clinical trials to be conducted in accordance with its guidance.

The psychiatrist leading the company’s involvement in alternative forms of therapy for mental conditions, Dr. Eric Alcera, noted that while more research was needed, the results thus far had shown promise.

The psychedelic legalization movement has gained traction across the country in the last few years, as more cities have approved laws to decriminalize the compounds. When it comes to states, however, only two have approved similar laws.

The first to do so was Oregon, which decriminalized psilocybin and legalized it for nonsupervised medical use in 2020. The state of Colorado followed suit in 2022, decriminalizing psilocybin and other psychedelics for personal use. Other states are also pursuing similar measures, among them California, Massachusetts and Pennsylvania.

With other startups such as Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) also conducting their own drug-development programs, it is only a matter of time before many approved psychedelic treatments are available to the patients who are in dire need of effective alternatives to existing mental-health treatments. Regulatory reform at state and national level appears certain to follow.

Mind Medicine Inc. (MNMD), closed Friday's trading session at $3.59, off by 1.1019%, on 420,241 volume. The average volume for the last 3 months is 15.274M and the stock's 52-week low/high is $2.41/$5.01.

Newmont Corporation (NEM)

MarketClub Analysis, InvestorPlace, The Street, Schaeffer's, Kiplinger Today, StocksEarning, MarketBeat, The Online Investor, Investopedia, Market Report, Barchart, StreetAuthority Daily, Daily Trade Alert, Top Pros' Top Picks, TopStockAnalysts, StreetInsider, Louis Navellier, Streetwise Reports, QualityStocks, Daily Wealth, SmarTrend Newsletters, Zacks, Uncommon Wisdom, TradingMarkets, Money Morning,, PROFIT CONFIDENTIAL, Trades Of The Day, Wealth Daily, The Growth Stock Wire, TheStockAdvisor, The Wealth Report,, ProfitableTrading, Wall Street Grand, Cabot Wealth, StockEarnings, Trading Tips, Investing Signal, Market Intelligence Center Alert, Dividend Opportunities, TheStockAdvisors, The Best Newsletters, InvestorIntel, National Inflation Association, DividendStocks, Trading Markets, All about trends, AllPennyStocks, Market FN, Wyatt Investment Research, Energy and Capital, InvestmentHouse, Stockhouse, Money and Markets, Darwin Investing Network, MiningNewsWire, Buttonwood Research, TradingAuthority Daily, Wall Street Daily, InvestorsObserver Team, Daily Markets, Investment House, OTC Stock Pick, Street Insider, Investors Alley, Investiv, Money Wealth Matters, Wall Street Greek, Eagle Financial Publications, StreetAlerts, The Tycoon Report, Dynamic Wealth Report, Investment U, StockTwits, The Stock Enthusiast, Daily Profit, Wealth Insider Alert, Short Term Wealth, Investing Futures, Early Bird, FNNO Newsletters, 24/7 Trader, MarketWatch, Trader Jack,, Market Authority, Trading Concepts, equities Canada, Investing Daily,, Insider Wealth Alert, INO Market Report, CNBC Breaking News, ChartAdvisor, Global Equity Alert, Candle Stick Forum, Global Equity Report, Total Wealth, SmallCap Network, Super Stock Picker, The Motley Fool, The Street Report, The Wall Street Transcript, One Hot Stock, TipRanks, Rick Saddler, Trade of the Week, UndiscoveredEquities, Vantage Wire, VectorVest, Wall Street Window, Weekly Wizards, The Weekly Options Trader, Penny Detectives, Investor Update, Investors Insights, Jim Cramer, Leeb's Market Forecast, MarketClub, Navellier Growth, Small Cap Firm, OTCPicks, Seeking Alpha, Penny Stock Buzz, PennyStockProphet, Power Profit Trades, Profitable Trader Authority, Profits Run, Investor Guide and Normandy Investment Research reported earlier on Newmont Corporation (NEM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Telfer mine located in Pilbara, Western Australia, has halted its processing operations following cracks that were detected at a tailings dam on site. Tailing dams are used to store mining operation byproducts, which can be toxic on mine sites.

The gold and copper and silver mine, which was discovered by Newmont Corporation (NYSE: NEM) (TSX: NGT) in 1972, is situated 200 kilometers east of the towns of Nullagine and Marble Bar and 400 kilometers southeast of Port Hedland. The mine is located in the Great Sandy Desert of Western Australia, on the land of the Martu people.

Mineralization in the mine’s west dome extends to a depth of 1,500 meters while the main dome extends to a depth of 1,300 meters.

In its statement, the company said that seepage and cracking had been found on an internal embankment. This led to the activation of its response plan, which included the closure of some areas near the mine while monitoring and analysis was done using drone and radar technology.

About two weeks ago, a spokesperson of the Department of Energy, Mines, Industry Regulation and Safety revealed that the company had told them there was no water or tailings seeping from the embankment. Since then, Newmont has given the department a geotechnical update, which helped inform the basis of the prohibition notice issued by the WorkSafe inspector. The notice, which limited the use of the tailings facility, was issued roughly two days after the company’s engineer of record stated that the stability of the impacted facilities was okay.

Sally North, acting WorkSafe commissioner, stated that the notice required that the operator restrict use of the affected area of the tailings facility until repairs were done. The department continues to collaborate with Newmont to make sure monitoring results don’t show any impact to the quality of groundwater as a result of the cracks identified.

Despite the suspension of processing, operations at the mine are still in full swing. A Newmont spokesperson stated recently that the company was liaising with regulators to smooth the path for the facility’s reopening. The spokesperson also revealed that the company would conduct a post-incident review to identify the root cause of this issue and determine ways to prevent it from occurring again.

Roger Cook, Western Australia’s premier, stated that the government expected to be able to make sure that the facility operated safely and with all environmental conditions taken into account. Currently, WorkSafe Mines Safety inspectors continue to monitor the situation.

Newmont Corporation (NEM), closed Friday's trading session at $34.58, off by 0.11554%, on 10,724,255 volume. The average volume for the last 3 months is 19.408M and the stock's 52-week low/high is $33.585/$60.08.

Tilray Brands Inc. (TLRY)

Schaeffer's, InvestorPlace, StocksEarning, The Street, StockEarnings, QualityStocks, MarketClub Analysis, MarketBeat, Trades Of The Day, Daily Trade Alert, StockMarketWatch, Kiplinger Today, StreetInsider, The Online Investor, Wealth Insider Alert, Market Intelligence Center Alert, BUYINS.NET, Zacks, Investopedia, CFN Media Group, CNBC Breaking News, Early Bird, The Street Report, Daily Profit, INO Market Report, StreetAuthority Daily, Inside Trading, The Rich Investor,, Top Pros' Top Picks, FreeRealTime, InvestmentHouse, Trading For Keeps, Trading Concepts, Eagle Financial Publications, InvestorsObserver Team, Investors Alley, Investment House, Outsider Club, wyatt research newsletter, Wealth Daily, VectorVest, TheTradingReport, The Night Owl, StrategicTechInvestor, Money Morning, Rick Saddler, InvestorsUnderground, AllPennyStocks, MarketClub,, Louis Navellier, Jim Cramer, Jason Bond and Stock Up Featured reported earlier on Tilray Brands Inc. (TLRY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Thailand’s recent political shift has set the stage for the introduction of fresh marijuana legislation, marking a major turnaround only 18 months after the nation took steps toward decriminalizing the substance.

The initial lenient regulations sparked a flourishing marijuana industry, serving both locals and tourists across southeast Asia. However, the conservative coalition government, which assumed power late last year, has pledged to enforce stricter rules, restricting marijuana usage solely to medical purposes.

Last week, the nation’s health ministry unveiled a draft measure outlining severe penalties, including high fines and potential one-year prison sentences for violators. The proposed legislation expressly limits marijuana and related products to medical applications. This aligns with Prime Minister Srettha Thavisin’s commitment in September to change marijuana regulations within the first six months in office, reinforcing the government’s focus on medical use exclusively.

Although public cannabis consumption has always been illegal, the impending laws go further by prohibiting marketing and advertising campaigns for all marijuana products. An earlier version of the bill faced parliamentary rejection in November, but the current government remains steadfast in its determination to regulate recreational marijuana.

Thavisin has consistently emphasized the severity of the drug-abuse issue in Thailand through various media platforms. The proposed legislation represents a stark departure from the June 2022 milestone when Thailand became the first Asian country to fully decriminalize marijuana, a historic move in a region where severe penalties, including death sentences, are common for marijuana-related offenses.

While medical cannabis gained legal status in Thailand in 2018, full decriminalization allowed for the cultivation, trade and use of hemp and cannabis products without criminal repercussions. The subsequent proliferation of marijuana-related businesses, including cafes, dispensaries and hemp spas, attracted considerable attention, turning cities such as Bangkok and Chiang Mai into hot spots for weed festivals and tourist attractions.

Former health minister Anutin Charnvirakul stated in a CNN interview that the intent of original legislation was never to endorse public recreational marijuana use, emphasizing the promotion of marijuana for medical purposes.

Despite protests from prolegislation advocates, including the Future Marijuana Network, the government appears resolute in its decision to pivot away from the previously permissive stance on marijuana. Kitty Chopaka, a marijuana entrepreneur and advocate based in Bangkok, labeled the government’s move an unexpected response, expressing disappointment while highlighting that the momentum for marijuana as a narcotic has irreversibly shifted.

The ongoing debate underscores the complexities surrounding marijuana regulation in Thailand, impacting various stakeholders from farmers and small business owners to advocates emphasizing the importance of public involvement.

This policy reversal in Thailand could come as a disappointment to entities such as Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY) that had hoped for more international markets opening up on the Asian continent and elsewhere.

Tilray Brands Inc. (TLRY), closed Friday's trading session at $2, up 3.0928%, on 21,473,792 volume. The average volume for the last 3 months is 44,404 and the stock's 52-week low/high is $1.50/$3.59.

The QualityStocks Company Corner

Turbo Energy S.A. (NASDAQ: TURB)

The QualityStocks Daily Newsletter would like to spotlight Turbo Energy S.A. (NASDAQ: TURB).

Whilst the European Union has been hugely successful in growing its renewable energy generation capacity, the bloc's energy storage infrastructure has yet to catch up

Turbo Energy's innovative product offering has sought to address this concern for households, providing consumers with an all-in-one AI-powered energy storage solution

AI is playing an increasingly transformative role within advanced energy storage technologies, helping consumers optimize their energy usage and maximize savings

During the depths of the European winter in 2022, renewable energy sources generated more of the EU's energy than fossil fuels for the first time ever. Coal power usage fell by 11 percent and gas by 13 percent despite initial fears that regional countries would have to resort to extensive coal usage as the bloc tried to wean itself off its historical dependence on Russian gas. Nonetheless and remarkably – among the 18 European countries that still utilize coal power as a source of energy, 15 reduced their coal generation in 2022. Turbo Energy (NASDAQ: TURB), a designer, developer and manufacturer of photovoltaic energy generation, management, and storage equipment has sought to address this issue within the rapidly growing residential solar market in Europe. The company's ‘SunBox Home' system encompasses an all-in-one AI-powered energy storage solution, designed to assist households in managing their power consumption. Directly linked to a household's solar panel generation unit, the SunBox system allows users to choose between settings including ‘maximum consumption' or ‘maximum savings', conserve a portion of its energy reserves in the event of unexpected electricity blackouts or rather, sell excess power back onto the grid.  The groundbreaking energy storage system additionally boasts the capacity to track weather forecasts, thus ensuring its batteries are fully charged in the event of a storm (

Turbo Energy S.A. (NASDAQ: TURB) designs, develops and distributes equipment for the generation, management and storage of photovoltaic energy in Spain, Europe and internationally.

Turbo Energy’s products include lithium-ion batteries and inverters. Additionally, the company recently launched its flagship product, the Sunbox, an all-in-one device that integrates most of the equipment required for a residential photovoltaic installation. The Sunbox is powered by AI and features a software system that monitors the generation, use and management of photovoltaic energy by analyzing large amounts of data related to energy generation, consumption, market prices and weather forecasts. This AI system optimizes battery usage, reducing electricity bills and providing peak-use reduction and uninterruptible power supply functions.

Turbo Energy currently sells its photovoltaic energy equipment primarily through distributors for residential consumers in Spain, but it possesses the expertise and international perspective to expand its product portfolio into industrial and commercial scale and markets, as well as advancing the internationalization process it has already started. The company plans to expand into the industrial photovoltaic sector with its new Sunbox, launched in 2023, in higher power and capacity variants. Its goal is to become a significant player in this sector and contribute to the growth of renewable energy solutions.

The company was incorporated in 2013 and is based in Valencia, Spain. It operates as a subsidiary of Umbrella Solar Investment S.A.


Lithium-Ion Batteries

Turbo Energy is one of the leading companies that introduced lithium-ion batteries for photovoltaic energy storage in Spain. Primarily for the home energy storage market, the company’s batteries have capacities from 2.24 kWh to 5.1 kWh in 24 and 48 volts. In addition, its 48V / 5.1 kWh units are available in a dual battery system.


The inverter converts the direct current produced by the photovoltaic panels into alternating current that can be used by household appliances. It also regulates battery charging and discharging based on energy needs and optimizes utilization of generated renewable energy. Turbo Energy currently offers multiple models that cover most household installations.

All-in-One Sunbox

This product incorporates inverters, batteries and the rest of the components necessary to operate and protect the photovoltaic installation. This saves installation cost and assembly and configuration time while preventing errors. Notably, the latest Sunbox models also offer an EV charging option.

Software System

In communication with the inverter, the company’s software monitors energy flows between the photovoltaic panels, household consumption, storage and an optional electric vehicle charging station. The software allows users to customize an automatic backup mode based on weather forecasts, or manually select which part of the battery will be reserved for possible power outages. It also allows the battery to be used in a peak shaving mode, which leverages AI to trigger battery power when grid energy is most expensive, effectively reducing the amount of high-cost power drawn from the grid.

Market Opportunity

According to a report by Fortune Business Insights, a global research and reporting firm, the solar energy storage battery market was estimated to be worth $3.33 billion in 2022 and is projected to reach a value of more than $20 billion by 2030, marking a CAGR of 24.2% over the forecast period.

These batteries are crucial components of renewable energy systems, allowing for the storage of excess electricity generated by solar panels, so it can be used during times of no or low sunlight. By storing energy and supplying it when needed, these batteries reduce reliance on the power grid and maximize self-consumption while helping users avoid peak electricity rates. They also contribute to the transition toward a cleaner and more sustainable energy future by enabling residential consumers and businesses to use solar power even when the sun is not shining.

Management Team

Enrique Selva Bellvís is the CEO and founder of the Umbrella Group. In addition, he serves as vice-president of the Valencian Association of Energy Sector Companies industry group. Before his career in the solar energy sector, he was the founder and CEO of Innova Ingenieros Consultores. He holds a degree in industrial engineering with a specialization in energy from the Polytechnic University of Valencia and completed the Management Development Programme at the IESE Business School.

Mariano Soria is the Chief Innovation Officer for the Umbrella Group and serves as General Manager of Turbo Energy. He was CEO of Punt Moble XXI S.L. and continues to serve on that company’s board. Before that, he was the General Manager of REJMAR S.A., a land development company. He received his degree in industrial engineering and industrial organization from the Polytechnic University of Valencia, and his MBA from the European University of Madrid.

Alejandro Moragues is CFO of Turbo Energy. Previously, he held the position of Senior Corporate Auditor for U.S. company Euronet Worldwide Inc. and was an external auditor for PricewaterhouseCoopers. He holds a bachelor’s degree in business administration and management from the Polytechnic University of Valencia.

Manuel Cercos is Chief Commercial Officer at Turbo Energy. Previously, he held positions at Técnicas Aplicadas en Baterías S.L., where he served as Sales Director and Sales Manager. Before that, he worked as a Sales Technician at DAISA.

Turbo Energy S.A. (NASDAQ: TURB), closed Friday's trading session at $0.9, up 2.2611%, on 7,745 volume. The average volume for the last 3 months is 110,140 and the stock's 52-week low/high is $0.861/$7.90.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has appointed a biotech veteran to its board of directors. The company announced that Amy Mahery, a highly accomplished biopharmaceutical industry executive, will join the company's board effective upon completion of financing. With more than 20 years of experience working with large and small companies in common and rare conditions, Mahery brings impressive expertise in the commercialization and launch of drugs in varied therapeutic areas, including oncology, neurology, and immunology, to her new responsibilities. She currently serves as the chief commercial officer of Roivant Sciences, a $9 billion market cap biopharmaceutical company. She has also served in a variety of leadership roles in sales, marketing and market access in both global and U.S. companies, including EMD Serono Inc. (Merck KGaA).

"We are incredibly pleased to welcome Amy to the board," said CNS Pharmaceuticals board chair Faith L. Charles in the press release. "She is a proven commercial leader with a wealth of knowledge and expertise amassed over the course of her 20-plus years in the industry. As the company continues to advance Berubicin toward completion of its global potentially pivotal clinical trial and potential regulatory approval, her guidance, insight and vast pharma industry network will truly be invaluable. We remain committed to serving GBM patients in desperate need of a treatment, and look forward to leveraging Amy's extensive experience and commercial leadership to assist in positioning the company for success."

To view the full press release, visit

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Friday's trading session at $0.7799, up 12.4585%, on 255,588 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $7.90/$.

Recent News

InMed Pharmaceuticals Inc. (NASDAQ: INM)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals Inc. (NASDAQ: INM).

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, announced that CEO Eric A Adams will be participating in the upcoming Water Tower Research Fireside Chat Series. This month's chat is scheduled to begin at 1 p.m. ET on Jan. 25, 2024. According to the announcement, topics discussed during the event will include an overview of InMed's pharmaceutical pipeline in Alzheimer's and ocular as well as a discussion about cannabinoids and their possible role in the treatment of Alzheimer's. In addition, the chat will include a look at upcoming 2024 milestone in both InMed's pharmaceutical drug development as well as  BayMedica's health and wellness initiatives. A replay of the webcast will be available to view following the presentation. A shareholder communication and engagement platform powered by senior industry experts with significant Wall Street experience, Water Tower Research is committed to creating, delivering and maintain the information flow required to build and preserve relationships with every stakeholder and potential investor.

To register for the webcast, visit

To view the full press release, visit

InMed Pharmaceuticals Inc. (NASDAQ: INM) is a global leader in the manufacturing and clinical development of rare cannabinoids. InMed is a clinical stage company developing cannabinoid-based pharmaceutical drug candidates, as well as manufacturing technologies for pharmaceutical-grade rare cannabinoids.

The company is dedicated to delivering new therapeutic alternatives to treat conditions with high unmet medical needs. The company is also developing a proprietary manufacturing technology to produce pharmaceutical-grade rare cannabinoids in the lab and has recently announced an LOI to acquire a leading rare cannabinoid manufacturer.

Research and Technology

There are more than 100 rare cannabinoids found in only trace amounts in the cannabis plant, together making up less than 1% of the plant’s biomass. InMed is initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need. Preclinical studies of CBN demonstrated an excellent safety profile and showed CBN has potential for therapeutic benefit over other cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD).

Evidence suggests there may be great therapeutic potential in rare cannabinoids. Each has a specific chemical structure, and different cannabinoids have been observed to have distinct physiological properties in humans, including therapeutic potential for specific diseases as well as unique safety profiles. CBN is the active pharmaceutical ingredient (API) in InMed’s two lead programs for dermatological and ocular diseases.

InMed’s most advanced compound, INM-755, is a CBN topical cream under clinical development for the treatment of epidermolysis bullosa, a severe genetic skin disorder. To date, INM-755 has been evaluated in two Phase 1 clinical trials in healthy volunteers. InMed has filed Clinical Trial Applications in several countries as part of a global Phase 2 clinical trial of INM-755 (cannabinol) cream in epidermolysis bullosa. Responses from the National Competent Authorities and Ethics Committees are expected throughout the summer of 2021.

InMed is also involved in developing INM-088, an ocular CBN formulation being researched for the treatment of glaucoma, the second leading cause of blindness in the developed world. InMed is currently evaluating several formulations to deliver CBN into the eye to address issues of dosing frequency, side effects and treatment penetration. INM-088 is being designed for topical delivery to the eye. This localized delivery results in very little drug being absorbed or migrating into the bloodstream, thus minimizing potential adverse side effects. INM-088 shows promise to reduce intraocular pressure and provide neuroprotection of the eye.


The limited availability of rare cannabinoids like CBN makes them economically impractical to extract directly from the plant for pharmaceutical use. InMed is developing IntegraSyn, a cannabinoid synthesis manufacturing system to create rare cannabinoids in the lab that are bioidentical to the compounds derived from the cannabis plant. IntegraSyn uses multiple standard pharmaceutical processes and has achieved a cannabinoid yield of 5 grams per liter, surpassing commercial viability and significantly exceeding currently reported industry yields. InMed is now focusing on manufacturing scale-up to larger batch sizes while continuing process optimization, targeting increased cannabinoid yield and further reducing overall cost of goods.

BayMedica Inc. Acquisition

On June 29, 2021, InMed announced it had entered into a non-binding letter of intent to acquire BayMedica Inc., a private company based in Nevada and California that specializes in the manufacture and commercialization of rare cannabinoids.

As noted in the news release, BayMedica is a revenue-stage biotechnology company leveraging its significant expertise in synthetic biology and pharmaceutical chemistry to develop efficient, scalable and proprietary manufacturing approaches to produce high quality, regulatory-compliant rare cannabinoids for consumer applications. BayMedica is currently commercializing the rare cannabinoid CBC (cannabichromene) as a B2B supplier to distributors and manufacturers marketing products in the health and wellness sector. BayMedica is planning additional rare cannabinoid launches for the coming year.

Pursuant to the indicative terms of the LOI, InMed and BayMedica intend to negotiate and enter into a definitive agreement under which InMed would acquire 100% of BayMedica in exchange for 1.6 million InMed common shares to be issued to BayMedica’s equity and convertible debt holders, with any such issued InMed common shares being subject to a six-month contractual hold period.

Market Outlook

There is a rapidly growing demand for rare cannabinoids. However, their low natural concentration makes traditional harvesting of these compounds cost prohibitive. Biosynthesis allows production of rare cannabinoids in the lab that are bioidentical to compounds found in nature, with significantly higher yields which reduce costs. Biosynthesis can produce pharmaceutical-grade, bioidentical, THC-free compounds at a cost that’s 70 to 90 percent less than wholesale prices of naturally harvested rare cannabinoids.

Cannabinoid-based pharmaceuticals are expected to overtake the market as rare cannabinoids become less expensive and more available. According to Statista, the value of the consumer market for cannabinoid-based pharmaceuticals in the United States is forecast to grow to $25 billion by 2025 and to $50 billion by 2029, with cannabinoid-based pharmaceuticals used to treat health conditions including pain, respiratory conditions, autoimmune conditions and more.

Management Team

Eric A. Adams has been CEO and president of InMed since June 2016. He has more than 25 years of experience in establishing corporate entities, capital formation, global market development, mergers and acquisitions, licensing and corporate governance. He previously served as CEO at enGene Inc. Prior to enGene, he held senior positions in global market development with QLT Inc. (Vancouver), Advanced Tissue Sciences Inc. (La Jolla, CA), Abbott Laboratories (Chicago, IL) and Fresenius AG (Germany).

Bruce S. Colwill is InMed’s CFO. He has more than 25 years of financial leadership experience in public and private companies. Prior to InMed, he served as CFO of General Fusion Inc., a private clean energy company. He was also CFO at Entrée Resources Inc., a mineral exploration company, from 2011 to 2016. He has held CFO roles at Neuromed Pharmaceuticals Ltd., Response Biomedical Corp, Forbes Medi-Tech Inc. and Euronet Worldwide Inc.

Alexandra D.J. Mancini is Senior Vice President, Clinical and Regulatory Affairs at InMed. She has more than 30 years of global biopharmaceutical research and development experience. She has been an executive with numerous biotech companies, including senior vice president of Clinical and Regulatory Affairs at Sirius Genomics; senior vice president of Clinical and Regulatory Affairs at INEX Pharmaceuticals; and vice president of Regulatory Affairs at QLT Inc.

Eric C. Hsu is Senior Vice President, Pre-Clinical Research and Development at InMed. He joined InMed with more than 18 years of scientific leadership experience in the field of gene therapy. He has held various positions within enGene Inc., including vice president of Research and vice president of Scientific Affairs and Operations. He received his Doctorate from the Department of Medical Biophysics at the University of Toronto.

Michael Woudenberg is Vice President, Chemistry, Manufacturing and Controls at InMed. He has more than 20 years of successful drug development, process engineering, GMP manufacturing and leadership experience. He has held positions with 3M, Cardiome Pharma, Arbutus Biopharma and, most recently, was Managing Director of Phyton Biotech LLC.

InMed Pharmaceuticals Inc. (INM), closed Friday's trading session at $0.3585, up 0.985915%, on 24,652 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.2913/$2.33.

Recent News

Horizon Fintex | Upstream

The QualityStocks Daily Newsletter would like to spotlight Horizon Fintex | Upstream

blog written by Vanessa Malone highlights the recent granting of approval by the U.S. Securities and Exchange Commission for the first-ever U.S.-listed exchange-traded funds ("ETFs") designed to track the performance of bitcoin. The development is widely regarded within the industry as a significant and pivotal moment for the cryptocurrency and greater blockchain sector. The piece describes ETFs as publicly traded investment vehicles that track the value of an underlying asset. Spot bitcoin ETFs are described as investment vehicles that provide ordinary investors exposure to the price moves of bitcoin from their regular brokerage accounts.

"The purpose of this kind of ETF is to mirror the price of bitcoins in the crypto market so investors can get exposure to bitcoin without going through the process of opening an account on a crypto exchange, creating a digital wallet, connecting the two, and holding their own crypto… The recent approval of bitcoin ETFs marks a significant milestone in the cryptocurrency landscape, ushering in a new era of more regulatory clarity… According to an interview from CNBC with Coinbase CEO, Brian Armstrong, 52 million Americans already use crypto. This is despite the barriers to entry, which include the complexities of crypto exchanges, digital wallets and private keys, which can be intimidating to some. A bitcoin ETF removes some of these barriers, bringing digital currency to both retail investors and institutions who can gain exposure to this asset class through traditional brokerage accounts. As also stated by Armstrong in the CNBC interview, this move is expected to inject significant liquidity into the sector," Malone writes.

"As a smart-contract powered market and trading app, Upstream finds the news very promising. This development not only provides investors with a more accessible avenue to participate in the crypto market but also has broader implications for the adoption of blockchain technology. With clearer regulations in place, market participants may find themselves more comfortable exploring the benefits of smart-contract powered applications. The trust instilled by the approval of bitcoin ETFs could lead to increased confidence in utilizing blockchain-powered markets, such as Upstream, where the benefits of decentralized technology are harnessed to create a more seamless and secure securities trading experience for issuers and investors."

To view the full blog, visit

Horizon Fintex is a software business specializing in compliant securities solutions. The company aims to facilitate the future of capital markets by leveraging the regulatory experience of Wall Street bankers and the proven track record of technology veterans to bring focus to compliance, efficiency, security and transparency.

Horizon’s flagship product is the revolutionary trading app ‘Upstream’, a MERJ Exchange Market, and the first regulated market powered by a blockchain to offer both digital securities and NFT trading. Upstream traders experience T+0 settlement, best bids and offers displayed on a transparent public orderbook that prevents predatory market practices – all from a user-friendly trading app.


Horizon Fintex offers a full suite of end-to-end blockchain-enhanced software solutions to create a seamless experience for both issuers and investors. Its product suite includes:

  • Securitization & IssuanceETSware is an end-to-end Electronic Trading System streamlining capital raising from primary issuance through compliant secondary trading.
  • KYC Compliance OnboardingKYCware is a white label Know Your Customer (KYC) and Anti-Money Laundering (AML) compliance software solution offering best-in-class cryptographic security to compliantly onboard and verify user identity through a smartphone application.
  • AML Screening SoftwareAMLCop offers advanced Anti-Money Laundering (AML) software to streamline the verification of user details against a proprietary database of global sanctions, politically exposed persons (PEPs) and watchlists.
  • Cap. Table Management ToolsCustodyWare equips registered U.S. transfer agents with next-generation cap. table management software to manage securities on behalf of their clients pursuant to an SEC-registered or exempt securities offering.
  • Exchange & Trading App TechnologyOpen Order Book offers Ethereum blockchain securities exchange software to power the next generation of trading venues for digital assets.

Upstream – The Horizon-Powered Trading App

Upstream is a joint venture with MERJ Exchange (, an affiliate of the World Federation of Exchanges.

Upstream aims to be the premiere global trading hub offering issuers around the world exposure to a digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD (fiat) to increase liquidity and enhance price discovery; while also offering investors access to dual-listed companies, IPOs, crowdfunded companies, U.S. & Int’l. equities, digital coupons and NFTs directly from a user-friendly trading app.

Upstream aims to unlock liquidity for investors of all levels while offering industry-leading levels of transparency, accessibility and investor protections enforced using Ethereum blockchain technology.

Management Team

Brian Collins is the CEO of Horizon Fintex. He founded the company in 2010. From 1999-2010, Mr. Collins was CEO of Abbey Technology in Switzerland, specializing in the design of trading software for Swiss banks. Prior to this, he worked for Credit Suisse in Zürich, designing and building proprietary equity trading solutions. Mr. Collins graduated in 1990 with a BS in Computer Systems from the University of Limerick, Ireland.

Mark Elenowitz is the company’s President. He is a Wall Street veteran with over 29 years of experience. Mr. Elenowitz was the co-founder of a U.S. broker dealer and is Managing Director of two U.S. broker dealers, responsible for advising clients on compliance, capital structure and capital market navigation. He was responsible for leading the first successful Reg A+ IPO of a company to list on the NYSE and others which listed directly onto Nasdaq. He is a noted speaker at Small Cap and Reg A events, including the SEC Small Business Forum, and has been profiled in BusinessWeek and CNBC, as well as several other publications. Mr. Elenowitz is a graduate of the University of Maryland School of Business and Management with a BS in Finance and holds Series 24, 62, 63, 79, 82 and 99 licenses.

Dr. Andrew Le Gear is the CTO of Horizon Fintex. Prior to joining the company in 2013, he worked as a software engineer with Dell Inc. (2012-2013) and Lehman Brothers and Nomura Plc. (2007-2012). Dr. Le Gear was a co-founder of Juneberi Ltd., a research-driven software tech start-up (2004-2007). He graduated in 2006 with a Ph.D. in Computer Science from the University of Limerick, Ireland.

Peter Hall is the company’s CIO. Prior to joining Horizon Fintex in 2011, he worked at Microsoft (2008-2011), Atos Origin (2004-2008) and AIT Group Plc. (1998-2002). Mr. Hall has held CISSP certification since 2010. He graduated from the University of Sheffield, UK in 1995 and earned an MS from the University College London in 2006.

Mike Boswell is the CFO of Horizon Fintex. A Wall Street veteran, he co-founded a U.S. broker dealer and served as Chief Compliance Officer. Mr. Boswell was also Managing Director of TriPoint Capital Advisors, a merchant banking and financial consulting company, and CFO of Mission Solutions Group, a privately held defense sector firm. He earned an MBA from John Hopkins University and a BS in Mechanical Engineering from the University of Maryland. Mr. Boswell holds Series 24, 62, 63, 79, 82 and 99 licenses.

Recent News


Diamond Lake Minerals Inc. (OTC: DLMI)

The QualityStocks Daily Newsletter would like to spotlight Diamond Lake Minerals Inc. (OTC: DLMI).

Diamond Lake Minerals (OTC: DLMI), which specializes in the development and support of digital assets and SEC-registered security tokens, was featured in a recent article by Fab World Today. The piece discusses Diamond Lake Minerals' commitment to a secure and transparent future, its goal to responsibly innovate and combine traditional businesses with the evolving landscape of digital assets, and its primary focus on developing and supporting SEC-registered security tokens, operating across various industries. The article highlights the company's significant growth since Brian J. Esposito took over as CEO, its unique structure, as well as Esposito's vision. The publication observed that Diamond Lake Minerals maintains a diversified portfolio with interests in various digital assets while security tokens take center stage. This strategic approach "positions the company uniquely in the market, offering a broad spectrum of opportunities." The piece further noted that Diamond Lake Minerals is actively shaping the future of digital assets and is "well-positioned for sustained success in the digital asset and security token space," given its clear mission, incorporation of cutting-edge techniques and technologies, experienced leadership, and a commitment to responsible business practices. Also spotlighted was the company's goal to "set a precedent for the industry, paving the way for a secure and transparent digital future" as it continues to perform and share its successes with stakeholders. Diamond Lake Minerals works with regulated SEC security token exchange partner INX to provide access to its companies before public trading commences.

To view the full article, visit

Diamond Lake Minerals Inc. (OTC: DLMI) is a multi-strategy operating company offering traditional investors an entry point to the future of digital securities. The company’s goal, through its established M&A roadmap, is to responsibly innovate and develop promising businesses that are likely to benefit from the ongoing shift toward digital assets. Through this approach, Diamond Lake Minerals provides traditional investors an opportunity to gain exposure to the emergence of regulated digital securities through a more familiar investment vehicle – the purchase of stock.

Founded in 1954 and headquartered in Salt Lake City, Diamond Lake Minerals is positioning itself as a leader in the digital asset and security token space. The company’s mission is to bring back to the public markets timeless business principles focused on healthy, sustainable growth and strong earnings with a goal of creating value for stakeholders in the modern digital world.

Diamond Lake Minerals believes the future of financial markets is set to be revolutionized by tokenization. Tokenization refers to the use of digital assets that can be traded via protocols with instantaneous settlement and reduced fees, eliminating the need for traditional clearing or settlement processes. Beyond efficiency, the emerging landscape emphasizes transparency, liquidity and security in asset management and investment.

With the backing of Esposito Intellectual Enterprises and its 20+ years of experience, Diamond Lake Minerals has access to the expertise of 110+ companies and 200+ joint ventures, along with knowledge spanning 25+ industries. The company is creating a vertically integrated ecosystem that encompasses various high-growth sectors. This integration aims to maximize operational efficiencies and profitability across all business units.

Products & Services Portfolio

Diamond Lake Minerals, guided by its strategic partnerships and future roadmap, envisions a diverse portfolio across multiple industries, as shown in the overview below. The company is poised to redefine the conglomerate model for the 21st century, with a focus on vertical integration, digital securities and sustainable growth.

Its target market segments include:

  • Fashion: DLMI seeks stakes in brands blending timeless aesthetics with tech influences.
  • Beauty: DLMI eyes partnerships with innovators elevating beauty through sustainable practices.
  • Real Estate: DLMI aims for interests in ventures modernizing property transactions via blockchain.
  • Hospitality: DLMI’s vision includes associations with enterprises enhancing guest experiences via tech integration.
  • Liquor: DLMI aspires to collaborate with unique distillers merging tradition and innovation.
  • IoT: DLMI intends to invest in solutions seamlessly connecting the digital and physical worlds.
  • Wireless: DLMI envisions stakes in wireless tech optimizing global communication.
  • Technology: DLMI plans to back pioneers driving the next tech revolution.
  • Maritime: DLMI seeks partnerships in maritime solutions emphasizing green initiatives.
  • Aviation: DLMI’s strategy includes holdings in aviation innovators focusing on efficiency.
  • Aerospace: DLMI aims to support ventures pushing boundaries in space exploration.
  • Education: DLMI collaborates with platforms revolutionizing learning through tech.
  • Charity: DLMI eyes alliances with charitable entities leveraging transparency via blockchain.
  • Healthcare: DLMI foresees investments in healthcare tech personalizing patient care.
  • TV: DLMI intends stakes in TV platforms innovating content delivery.
  • Film: DLMI aspires to support filmmakers merging storytelling with immersive tech.
  • Music: DLMI plans interests in music ventures amplifying artists through digital platforms.
  • Entertainment: DLMI targets stakes in platforms redefining entertainment paradigms.
  • IP: DLMI envisions collaborations safeguarding intellectual properties via tech solutions.
  • Data Management: DLMI seeks ventures optimizing data utilization and insights.
  • Data Storage: DLMI’s roadmap includes alliances with secure data storage solutions.
  • Streaming: DLMI intends to back streaming platforms prioritizing user experience.
  • Real World Assets: DLMI eyes investments translating tangible assets into digital value.
  • Gold & Silver: DLMI aims for stakes in platforms digitizing precious metal trading.
  • Sports: DLMI envisions collaborations enhancing sports experiences via tech integration.
  • Sports Technology: DLMI seeks ventures revolutionizing athlete performance and fan engagement.
  • Water: DLMI plans to back solutions ensuring water sustainability and accessibility.
  • Water Treatment: DLMI targets investments in eco-friendly water purification technologies.
  • Animation: DLMI eyes stakes in animation houses blending art with cutting-edge tech.
  • Studio Production: DLMI’s vision includes support for studios transforming content creation.
  • Consumer Products: DLMI seeks partnerships with brands prioritizing consumer-centric innovations.
  • Collectables: DLMI envisions collaborations with platforms digitizing unique collectibles.
  • Digital Assets: DLMI aims to invest in ventures maximizing the potential of digital ownership.
  • Web3: DLMI aspires to back pioneers ushering in the decentralized web era.
  • Identity Management: DLMI eyes solutions prioritizing user identity security in the digital space.
  • Media & Journalists: DLMI seeks alliances promoting unbiased reporting and content democratization.
  • Metaverse: DLMI envisions stakes in ventures crafting immersive virtual universes.
  • Space Economy: DLMI targets investments in ventures monetizing space exploration.
  • Modular Homes: DLMI plans interests in solutions revolutionizing home construction.
  • Financial Technology: DLMI seeks partnerships modernizing financial transactions.
  • Gaming: DLMI aims to back game developers enhancing user immersion.
  • Travel: DLMI eyes collaborations transforming travel experiences through tech.
  • Health & Wellness: DLMI’s strategy includes investments in holistic health tech solutions.
  • Augmented Reality: DLMI envisions stakes in AR platforms blurring reality and digital.
  • AI: DLMI seeks to support AI innovations humanizing tech interactions.
  • Esports: DLMI targets investments in platforms amplifying esports experiences.
  • Construction: DLMI plans to back ventures modernizing construction practices.
  • Virtual Reality: DLMI intends stakes in VR platforms offering alternate realities.
  • Retail Tech: DLMI envisions collaborations digitizing retail experiences.
  • Biotechnology: DLMI seeks ventures pushing boundaries in biotech innovations.

Market Opportunity

According to Diamond Lake Minerals’ business plan executive summary, the market for digital securities is projected to grow from $10 billion in 2022 to $1 trillion by 2028, a CAGR of 45% for the forecast period.

The global blockchain market value is expected to grow from an estimated $3 billion in 2020 to $39.7 billion by 2025, marking a CAGR of 67.3% for the period. Valued at $2.28 billion in 2021, the Security Token Offerings market is projected to grow at a CAGR of 19%. This growth is expected to be driven by the rising adoption of tokenization and the increasing prominence of STOs, especially in North America.

In addition, the global investment management market is projected to grow from a value of $100 trillion in 2020 to $178 trillion by 2025, recording a CAGR of 7.2% over the period.

Management Team

Brian J. Esposito is CEO of Diamond Lake Minerals. As founder and CEO of Esposito Intellectual Enterprises LLC, he brings over 20 years of diverse experience in sectors like manufacturing, technology, music and real estate, and is known for his global executive networking and balance sheet optimization skills.

Michael Reynolds is President and Director of Diamond Lake Minerals. With 35 years in private finance and M&A, he has been instrumental in growing companies like Herbalife through reverse acquisition, as well as elevating JB Oxford to $120 million in revenue. His expertise in operational management and business development ensures professional solutions for clients’ business interests.

Jon Karas is DLMI’s senior transaction and investment executive. As the CEO and co-founder of Akon Legacy Ventures, he structured, negotiated and closed numerous transactions focused on innovation and social impact in smart cities, blockchain, agriculture, mining and technology. He co-founded and led multiple companies in media and entertainment and was the driving force behind the development, financing and production of a broad range of film and television content.

Advisory Board

Anthony Scaramucci, Founder and Managing Partner of SkyBridge Capital and Chairman of SALT, brings to Diamond Lake Minerals unparalleled expertise in finance, technology and business strategy. He is expected to be instrumental in shaping DLMI’s strategic direction as the company continues to redefine the future of traditional and digital securities.

Larry Namer, Founder of E! Entertainment TV and President of Metan Global, boasts a remarkable career spanning more than half a century. He is an esteemed veteran of the entertainment industry, renowned for his influential contributions to cable television, live events, music and new media. He also leads LJN Media, a consulting firm known for its cross-industry expertise in technology, business and finance.

Andrew Fromm is a seasoned CEO and consultant with a focus on music publishing. He is known for his expertise in asset sales, songwriting and artist development. His extensive network extends beyond the music industry, showcasing his versatility and authority in the field.

Brandon Fugal is the Chairman of Colliers International in Utah and a former EY Entrepreneur of the Year. He has co-founded multiple ventures, including Coldwell Banker Commercial Advisors, Cypher, Axcend and Texas Growth Fund, and he is a recognized authority in real estate and entrepreneurship.

Michael Malik Sr. is a Detroit-based entrepreneur with a $750 million net worth, known for his pivotal role in legalizing gambling and developing major casino projects across the U.S., including Detroit’s MotorCity Casino and various Native American gaming ventures. He brings to Diamond Lake Minerals a wealth of experience and a proven track record in the gaming, sporting and entertainment industries spanning over five decades.

Raul Leal is an experienced CEO in the hospitality sector, known for his visionary leadership at SH Hotels & Resorts and former role at Virgin Hotels, where he secured over $500 million in funding and revolutionized guest experiences.

Agnes Budzyn, an accomplished entrepreneur and CEO of Bluedge Ventures, brings to the company a rich history in traditional finance and blockchain technology, serving on various global boards and committees. She has been recognized by the World Economic Forum and numerous institutions for her expertise and contributions to bridging legacy finance with emerging digital asset infrastructure.

Diamond Lake Minerals Inc. (OTC: DLMI), closed Friday's trading session at $5.25, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.35/$5.25.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle ("EV") manufacturer, today announced that its majority-owned Bollinger Motors has received vehicle orders for 40 B4, Class 4 EV trucks, valued at a total of approximately $6 million. According to the announcement, the company anticipates the 100% American-made Bollinger B4 chassis cab to begin production in mid-2024. The truck is expected to be eligible nationwide for a federal purchasing incentive of 30% of the cost of the vehicle, up to a total of $40,000, through the Inflation Reduction Act of 2022. The announcement noted that the purpose-built Bollinger B4 commercial trucks, which will be made in Michigan, have been designed to be custom-configured by fleets to fit their exact duty cycle needs. This design intends to make the transition to electric as seamless as possible with minimal downtime. In addition, the all-electric trucks' cabs feature a forward design that provides improved visibility and frees up space behind the driver for more cargo. "The B4 has been very well received to date and it's great to see our first 40 vehicle orders coming in well in advance of production start," said Robert Bollinger, CEO of Bollinger Motors.

To view the corresponding image, visit

To view the full press release, visit

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Friday's trading session at $7.82, off by 12.9176%, on 1,508,405 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $6.95/$10080.00.

Recent News

SenesTech Inc. (NASDAQ: SNES)

The QualityStocks Daily Newsletter would like to spotlight SenesTech Inc. (NASDAQ: SNES).

SenesTech, a rodent fertility control expert, just marked its entry into Hong Kong, Macau, and potentially mainland China with its distribution agreement with Fruit Tree Limited

This move marks a remarkable start to the 2024 calendar year while reflecting the company's commitment to creating shareholder value

It also opens SenesTech up to many exciting opportunities, among them market entry into what is arguably the largest pest control market on the planet

SenesTech (NASDAQ: SNES), a rodent fertility control expert and the inventor of the only EPA-registered contraceptive for male and female rats, just marked its entry into Hong Kong and Macau, with potential expansion into Mainland China. This move positions the company in one of the largest pest control markets globally, made possible through its distribution agreement with Fruit Tree Limited, which has just been finalized (

SenesTech Inc. (NASDAQ: SNES) is the rodent fertility control expert and the inventor of the only EPA-registered contraceptive for male and female rats. The company’s technology provides an innovative and humane method for managing rat populations.

SenesTech is focused on developing effective solutions that are grounded in science and proven through research, all while providing value to people, communities and the environment. The company’s passion is to create a healthier world by better controlling rat pest populations. This aim is critical, as, if left unchecked, a breeding pair of rats and their descendants can produce up to 15,000 pups after just one year.

The company strives for clean cities, efficient businesses and happy households – with a product that was scientifically designed to be effective without killing rats. SenesTech is committed to the sustainable, humane treatment of animals, improving the quality of all human life and enhancing environmental stewardship through the global application of its effective solution in fertility control technology.

SenesTech is headquartered in Phoenix, Arizona.


SenesTech’s first product, ContraPest®, applies revolutionary technology to a global challenge that has persisted since the Middle Ages – the proliferation of rats in urban and agricultural settings. ContraPest® targets the reproductive capabilities of Norway and roof rats. As a highly palatable liquid, the formulation promotes sustained consumption, helping to reduce fertility in both male and female rats, bringing populations down and keeping them down.

The company’s flagship offering can be used as part of integrated pest management (IPM) programs – fitting seamlessly into all IPM programs – to help reduce reproduction and magnify the success of these protocols, or as a standalone solution for customers who want to reduce or eliminate the use of lethal rodent control methods.

In multiple, independent field deployments, ContraPest was shown to reduce rat activity over 90% when added to an existing IPM program.

ContraPest® is registered federally as a General Use Product.

Delivery Systems and New Products

In July 2023, SenesTech began to distribute a new delivery system for ContraPest®, the Isolate Bait System™. This new delivery system brings to market a simple design that enables more efficient deployment, incorporates an enhanced formulation of ContraPest® that is expected to provide improved performance of the fertility control bait in the field and is paired with a new bait station that is more space-efficient and economical.

The other delivery systems available for ContraPest include the Ultimate Bait System™, a tank and tray in a larger format for use with more severe infestations, and the Elevate Bait System™, a unique delivery system that targets above ground infestations, as with roof rats.

SenesTech, as of August 2023, is also in the final stages of releasing a soft bait formulation, which provides the unique attributes of proven fertility control in an industry-familiar format demanded by big box retailers, key e-commerce channels and leading industry pest management professionals.

Market Opportunity

According to SenesTech’s figures, rats cause over $27 billion in damage to public and private infrastructure annually in the United States. Rats also destroy 20% of the global stored food supply every year by consuming or contaminating it.

Rats are known to spread at least 35 diseases, globally posing a dangerous risk to public health and safety. Not only does this age-old problem persist despite extensive campaigns to eradicate it, but multiple sources have reported that post-COVID rat populations have boomed.

Poison-based control methods sicken rats, and they typically die slowly. An animal that eats a poisoned rat may also sicken or die. The global rodenticide market is projected to be worth $1.7 billion by 2026.

In one case study, results reported by the customer showed a $5,000 investment in ContraPest® saved more than $500,000 annually in reduced labor, loss and damage.

Management Team

Joel Fruendt is SenesTech’s President and CEO. He has 15 years of executive leadership in the vector and pest control industries as Vice President and General Manager of Clarke Environmental Inc., a leading vector and pest control products and services company. He has extensive expertise in the development and manufacturing of EPA-registered chemical control products, and the commercialization and sale of those products. He received the ‘Smart Leaders’ award from Smart Business Magazine and holds a bachelor’s degree in business from Illinois Wesleyan University.

Tom Chesterman is CFO at SenesTech. He has over 20 years of experience as the CFO of public companies in the life science, tech and telecommunications industries. Most recently, he was the Vice President and Treasurer of GCI, a telecommunications company. Previous to that, he was the CFO of life science companies Bio-Rad Laboratories, Aradigm and Bionovo. He has a bachelor’s degree from Harvard University and an MBA from the University of California at Davis.

Dan Palasky is Chief Technical Officer at SenesTech. Previously he held the title of Vice President of Research & Development at PLZ Corp., a manufacturer of chemical consumer products, serving as the technical expert for its entire product portfolio. He started his career with Camie-Campbell, Inc., as a chemist in the R&D department. Mr. Palasky received his bachelor’s degree in chemical engineering from the Missouri University of Science & Technology and his MBA in Project Management from Aspen University.

SenesTech Inc. (NASDAQ: SNES), closed Friday's trading session at $0.7707, off by 8.3482%, on 215,548 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.52/$80.952.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

D-Wave Quantum (NYSE: QBTS) ("D-Wave"), a leader in quantum computing systems, software, and services and the world's first commercial supplier of quantum computers, has named former Secretary of the U.S. Department of Homeland Security Kirstjen Nielsen to its board of directors. A global expert and proven leader on security issues critical to the highest priorities of the United States, Secretary Nielsen has a vast background in enterprise risk, resiliency, cybersecurity and emerging threats.

Secretary Nielsen has held a variety of domestic and international government roles, including serving as a key member of the White House Homeland Security Council, helping create and run the Transportation Security Administration, and leading the World Economic Forum's Global Agenda Council on Risk and Resilience. She is well-versed in emerging technology policy, including artificial intelligence ("AI") and quantum, and has served in advisory roles to technology companies ranging from start-ups to Fortune 100 corporations.

According to the announcement, Secretary Nielsen believes that quantum computing has the potential to transform the way governments and businesses tackle operational complexities. She also notes that D-Wave is leading this evolution and is well positioned to capitalize on its unique strengths.

"It's a transformative time in quantum computing, as governments and businesses increasingly recognize the near-term value today's quantum solutions can deliver," said D-Wave CEO Dr. Alan Baratz in the press release. "It's also a transformative time for D-Wave, and we're incredibly excited to have Secretary Nielsen join the board to help the company accelerate quantum adoption and explore quantum's impact on AI and machine learning. As an attorney, public servant, and U.S. and international policy expert, she will bring valuable perspectives to the D-Wave board."

To view the full press release, visit

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer


With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service


D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Friday's trading session at $0.685, off by 3.0157%, on 965,749 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.3962/$3.20.

Recent News

PaxMedica Inc. (NASDAQ: PXMD)

The QualityStocks Daily Newsletter would like to spotlight PaxMedica Inc. (NASDAQ: PXMD).

New research has looked into the link between the cord blood lipid levels, autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) symptomatology. ASD and ADHD are neurodevelopmental disorders that affect the central nervous system, which is responsible for language, movement, memory, focusing and social skills.

It is common knowledge that early-life risk factors such as maternal inflammation and contaminant chemicals impact neurodevelopmental conditions, including ADHD and ASD. These conditions can cause changes in serological lipids, which make up about 60% of brain weight and are necessary for neurodevelopment.

For their research, the investigators utilized lipidomic analysis data from the Barwon Infant study to explore the link between ADHD, ASD and cord blood lipids. They assessed the link between peri- and prenatal factors and ADHD and ASD. The numerous studies on ASD that are also being conducted by various entities such as PaxMedica Inc. (NASDAQ: PXMD) could also reveal additional insights into the pathophysiology of this ailment, whose prevalence is becoming a major concern to health authorities around the world.

PaxMedica Inc. (NASDAQ: PXMD) is a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (APTs) for the treatment of Autism Spectrum Disorder (ASD) and other serious conditions with intractable neurologic symptoms.

The company’s lead programs are focused on ASD, for which there are currently no approved pharmacologic treatments that target its cause and symptoms. Currently used treatments only address the symptoms of the condition, rather than targeting the pathophysiology itself.

PaxMedica is on a promising path to address these unmet medical needs, bringing hope to millions. Anti-purinergic therapies target the excess production of purines in cells. An overexpression of purines can offset homeostasis and result in an overproduction of cellular adenosine triphosphate, the main energy molecule in all living cells.

The company is headquartered in Tarrytown, New York.

Product Pipeline

PaxMedica is building a robust pipeline of products targeting ASD and related neurodevelopmental conditions. The company’s lead product in development may help eliminate, reduce or modulate some of the more troublesome aspects of ASD. That would open the potential for people with autism to integrate their behavior with others more successfully and improve their lives.

PaxMedica’s lead programs, PAX-101 and PAX-102, utilize the company’s proprietary source of suramin sodium, a broadly acting anti-purinergic therapy that has been known for over 100 years. Its current pipeline includes:

  • PAX-101 (IV Suramin) for ASD – PAX-101 completed a Phase 2B study for ASD in 2021. Suramin is a broadly acting APT and has reported positive results from a dose range study. The results of PaxMedica’s Phase 2B study, which targeted 52 subjects across six sites in South Africa, were presented to AACAP in October 2021.
  • PAX-102 (Intranasal Suramin) – PaxMedica has developed a proprietary intranasal formulation of suramin that is currently being evaluated in ASD and other neurodevelopmental conditions.
  • PAX-101 for HAT – Given suramin’s historical use as a treatment for Human African Trypanosomiasis (HAT), or African Sleeping Sickness, the company is also developing PAX-101 as a treatment for HAT. PaxMedica’s most advanced program is the pursuit of PAX-101 for early-stage East African HAT.
  • Selective APTs – PaxMedica has conducted several preclinical studies to evaluate other APTs that are more selective to specific purinergic receptors and may offer additional benefits over suramin.

Market Opportunity

According to a report by Fortune Business Insights, a leading global market research company, the global ASD therapeutics market was estimated at $1.93 billion in 2022 and is projected to grow from $2.01 billion in 2023 to $3.42 billion by 2030, a CAGR of 7.9% over the forecast period. As there is no current treatment for the core symptoms of autism, PaxMedica believes the addressable market for PAX-101, if approved, could greatly exceed these forecasts.

Autistic disorder, Asperger’s Syndrome and Pervasive Development Disorder are the three main types of ASD, affecting millions of people globally. A 2020 report by the U.S. Centers for Disease Control & Prevention estimated that one in 36 children in the U.S. have been diagnosed with autism disorder.

Several factors are expected to contribute to market growth prospects. A growing prevalence of the condition globally and rising awareness coupled with available treatment options are key factors expected to drive ASD therapeutics market growth during the forecast period. Growing investment in R&D to find effective treatments is also expected to fuel global market growth.

Management Team

Howard Weisman is Chairman and CEO of PaxMedica. He has been a founder and CEO of several specialty pharma and medical device companies. Most recently, he was executive chairman and co-founder of Sofregen, a biotech company. He also served as CEO and president of Seventh Sense Biosystems, a medical device development company. He also was founder, chairman and CEO of EKR Therapeutics, a specialty pharmaceutical company, and founder and COO of ESP Pharma, a company focused on cardio and neurovascular products. He has a bachelor’s degree in chemistry from Rutgers University.

David Hough, M.D., is Chief Medical Officer at PaxMedica. He is a neuroscience clinical development consultant who previously served as vice president at Janssen Research and Development and in various leadership roles over 17 years. Most recently, he was the compound development team leader for SPRAVATO® for treatment-resistant depression. Prior to that, he was the schizophrenia disease area leader. He played a pivotal role in the development programs for oral INVEGA®, INVEGA SUSTENNA® and XEPLION® for schizophrenia. He is a graduate of West Point and is board certified in psychiatry.

Stephen Sheldon is COO and CFO at PaxMedica. He has served as CEO of Thailand-based specialty healthcare company Indochina Healthcare Co. Ltd. since 2015. Previously, he was a consultant for PricewaterhouseCoopers Healthcare Advisory in the Chicago office. He was responsible for developing specialty pharmacy patient programs, strategy development for specialty products and compliance programs. He has an MBA from Thunderbird School of Global Management and a bachelor’s degree in computer science and visual arts from Bowdoin College.

PaxMedica Inc. (NASDAQ: PXMD), closed Friday's trading session at $0.5674, off by 3.6672%, on 91,835 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.5601/$69.19.

Recent News

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0)

The QualityStocks Daily Newsletter would like to spotlight Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0).

FMW Media Works Corp.'s New to the Street, a nationally broadcasted business television production, announces airing episode 550 on the FOX Business Network , Monday, January 22, 2024, at 10:30 PM PT. "Sekur Privacy & Sekur Security – Weekly Hack" segment with internet privacy expert Mr. Alain Ghiai, CEO, Sekur Private Data, Ltd. (OTCQB: SWISF) (CSE: SKUR) (FRA: GDT0) ($SWISF) ( Sekur® ).

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0) is a Cybersecurity and Internet privacy provider of Swiss hosted solutions for secure and private communications. The company distributes a suite of encrypted e-mails, secure messengers and secure communication tools. Sekur Private Data Ltd. sells its products through its own website at, approved distributors, and telecommunications companies. Sekur Private Data Ltd. serves consumers, businesses and governments worldwide.

Customer information is completely confidential and safely stored in Switzerland using military grade security. All data, whether physical, network-based or encryption security, is stored in bank-approved, state-of-the-art ISO-certified data centers used by Swiss and global banks and most United Nations organizations, as well as many corporations and governmental organizations. All user data is protected by the Swiss Federal Data Protection Act and the Swiss Federal Data Protection Ordinance, which offer some of the strongest privacy protection in the world for both individuals and organizations.

The company owns 100% of its own infrastructure and, unlike its competitors, does not rely on third party cloud services like Amazon Web Services, Microsoft Azure Cloud or Google cloud infrastructure.

Sekur Private Data has chosen Switzerland to locate its data storage because of the country’s neutrality, independence, strong privacy laws, long standing political stability and excellent international relations. Switzerland is also home to several large multinational corporations and is ranked as having one of the strongest and most competitive economies in the world.

The company is headquartered in Toronto, Ontario.


Sekur Private Data distributes a privacy communications suite offering encrypted and private email, the only Swiss-hosted privacy VPN, and a secure and private messaging application. All solutions cater to consumers, SMBs, enterprises and governments.

  • SekurMail® is an encrypted email service offering a private, safe and powerful tool to communicate with everyone, either within the Sekur ecosystem or outside. SekurMail protects personal information and communications from being accessed by unauthorized parties. Its encryption and other security measures prevent messages from being intercepted, modified or tampered with, either in transit or while stored. SekurMail empowers the client to access information and communicate with anyone in the world, regardless of geographical or political barriers.
  • SekurVPN® creates a secure, encrypted connection between the client’s device and the Internet, giving clients access to the web safely and privately by routing their connections through a server and hiding their online actions. All the data sent and received is hidden from prying eyes. This includes the clients’ Internet Service Providers, as well as potential hackers and even government surveillance agencies. It can also help clients bypass geographical restrictions and censorship.
  • SekurMessenger® is a Swiss-hosted private and secure messaging communications app providing secure and private chat, self-deleting chat, voice recording and file transfer via any mobile device, tablet or desktop computer. Communications are transmitted only within secure servers. It’s designed for organizations that need to protect their flow of information and secure their communications with customers and partners. SekurMessenger is designed to provide military-grade encryption and privacy by ensuring that only the sender and intended recipient can read the messages exchanged. It works for both licensed users of the app and intended message recipients who do not have the app.

Market Opportunity

An analysis from ReportLinker forecasts that the global cybersecurity market will grow from an estimated $173.5 billion in 2022 to $266.2 billion by 2027, recording a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors that are driving cybersecurity market growth, according to the report.

The global data privacy software market was estimated to be worth $1.68 billion in 2021 and is expected to grow from $2.36 billion in 2022 to $25.85 billion by 2029, achieving an eye-popping 40.8% CAGR during the forecast period, according to a Fortune Business Insights report titled ‘Data Privacy Software Market 2022-2029’.

The widespread shift toward remote working culture, evolving government data privacy regulations and the rapidly increasing adoption of Internet-of-Things devices are among the major factors propelling market growth, per the report.

Management Team

Alain Ghiai is founder, CEO and Director at Sekur Private Data. He also founded GlobeX Data S.A. (GDSA) in 2007 and has served as Director and CEO since then. He founded GlobeX Data Inc. (GlobeX US) in August 2012 and has served as Director and CEO since that time. He attended the California College of Arts in San Francisco, where he earned a Bachelor of Architecture. He has over 15 years of experience in the software industry and was instrumental in taking Sekur Private Data public in July 2019.

Scott Davis, CPA, CGA, is CFO at Sekur Private Data. He is also a partner at Cross Davis & Company LLP Chartered Professional Accountants. His experience includes CFO positions at several companies listed on the TSX Venture Exchange. He spent four years at Appleby as an Assistant Financial Controller. Prior to that, he spent two years at Davison & Company Chartered Professional Accountants as Auditor, five years with Pacific Opportunity Capital as Accounting Manager and two years at Jacobson Soda and Hosak, Chartered Professional Accountants. He obtained his CPA, CGA in 2003.

Learn more about the company’s management team by visiting its corporate page.

Sekur Private Data Ltd. (OTCQB: SWISF), closed Friday's trading session at $0.0514, off by 6.6134%, on 122,000 volume. The average volume for the last 3 months is 109,929 and the stock's 52-week low/high is $0.0295/$0.1576.

Recent News

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF)

The QualityStocks Daily Newsletter would like to spotlight Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF).

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) is a publicly traded exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec.

The company has an option to acquire a 99% interest in the highly prospective Iska Iska Property, classified as a silver-tin polymetallic epithermal-porphyry complex, a significant mineral deposit type in the Potosi Department of southern Bolivia. Iska Iska is a road-accessible, royalty-free property.

Eloro also owns an 82% interest in the La Victoria Gold/Silver Project, located in the North-Central Mineral Belt of Peru, some 50 kilometers south of Barrick’s Lagunas Norte Gold Mine and Pan American Silver’s La Arena Gold Mine. La Victoria consists of eight mining concessions and eight mining claims encompassing approximately 89 square kilometers. La Victoria has good infrastructure, with access to road, water and electricity, and is located at an altitude that ranges from 3,150 meters to 4,400 meters above sea level.

The company has a strong management and technical team working diligently to uncover the value of both Iska Iska and La Victoria. Eloro is based in Toronto, Canada.


Iska Iska – Potosi, Bolivia

Iska Iska is associated with a Miocene possibly collapsed/resurgent caldera, emplaced on Ordovician age rocks with major breccia pipes, dacitic domes and hydrothermal breccias. The property is wholly controlled by the title holder, Empresa Minera Villegas S.R.L. It is located 48 kilometers north of Tupiza city, in the Sud Chichas Province of the Department of Potosi. This is an important mineral deposit type in the prolific South Mineral Belt of Bolivia. Eloro commissioned a NI 43-101 Technical Report on Iska Iska, which was completed by Micon International Limited and is available on Eloro’s website and under its filings on SEDAR.

A fully financed drill program is currently underway on the property, situated near world-class deposits including Silver Sand, San Bartolomé, Pulacayo, San Cristobal, San Vicente, Chorolque, Tasna, Choroma and Siete Suyos. Iska Iska is in the southwest part of the Eastern Cordillera, which hosts a number of major polymetallic mines and mineral deposits. Drilling and continuous channel sampling results have demonstrated some very high metal values, especially silver and tin, within an immense system, where mineralization has been encountered in every drill hole to date. The company believes there is excellent potential for world-class bulk mineable deposits.

La Victoria – Ancash, Peru

The La Victoria project, targeting gold and silver production, is situated near world-class, low-cost gold producers Pan American Silver and Barrick Gold Corporation. Located in Ancash Department, La Victoria sits on the western slopes of the Peruvian Andes. The property is located 12 hours from Lima, with a travel distance of 600 kilometers. The nearest road accessible population centers from La Victoria are Huandoval, Pallasca and Cabana. The project includes four principal mineralized zones in Peru’s prolific North-Central Mineral Belt – San Markito, Victoria, Victoria South and Ccori Orcco – with excellent potential for gold discovery. Operations at La Victoria are planned to proceed with a 2,000-meter diamond drilling program to test targets to outline potential resources at San Markito. Trenching and sampling confirmed high silver values and veins at San Markito in 2020.

Market Outlook

According to industry association The Silver Institute, the outlook for silver demand is exceptionally promising, with global demand forecast to rise to a record high of 1.112 billion ounces in 2022. The increase will be driven by record silver industrial fabrication, which is forecast to improve by 5%, as silver’s use expands primarily in solar energy and electric vehicle (EV) manufacturing. The institute states that government commitments to carbon neutrality have resulted in a rapid expansion of green energy projects, driving record photovoltaic panel installations which are expected to lift silver demand in this segment to an all-time high in 2022.

Rising demand in the electronics industry is also boosting the demand for tin, which is primarily used in solder. The electronics and electrical industries use solders containing 40-70% tin, which provide strong and reliable joints under a variety of environmental conditions. At present, the majority of the assemblers are using patented tin-and-copper-based solders. Mordor Intelligence estimated tin demand at 387 kilotons in 2021 and forecasts demand growth of 2.5% annually through 2027. Over the medium term, surging demand from the EV market and increasing applications in the electrical and electronics industry is expected to drive the market.

Management Team

Thomas G. Larsen is CEO of Eloro. He has more than 40 years of experience in the investment industry, specializing in corporate finance and management of junior resource companies, raising in excess of C$200 million. He previously held the position of President and Chief Executive Officer of Champion Iron Limited. Prior to that, he was President and Chief Executive Officer of Champion Iron Mines Limited.

Dr. Bill Pearson is Executive VP of Exploration for Eloro. He has more than 40 years of direct experience in the exploration and production of minerals worldwide. He played an integral role in the acquisitions of Desert Sun Mining Corp. by Yamana Gold in 2006 and Central Sun Mining by B2 Gold in 2009. He was formerly VP Exploration at Desert Sun Mining and Senior VP at Central Sun Mining.

Miles Nagamatsu, CPA, is CFO at Eloro. He has over 30 years of experience in accounting, management, lending, restructurings and turnarounds. Since 1993, he has acted as a CFO of public and private companies primarily in the mineral exploration and investment management sectors. He holds a Bachelor of Commerce degree from McMaster University.

Osvaldo Arce Burgoa is General Manager at Eloro. He is a geological and mineral processing engineer with 26 years of experience in Bolivia. He is a former President of the Bolivian Geological Society, Main Technical Advisor of the National Mining Corporation (COMIBOL) and has served as exploration manager and chief geologist at various mining and exploration companies. He has authored two books on Bolivian geology and holds a doctorate in mining engineering from Tohoku University in Sendai, Japan.

Eloro Resources Ltd. (OTCQX: ELRRF), closed Friday's trading session at $1.255, up 2.449%, on 19,501 volume. The average volume for the last 3 months is 26,565 and the stock's 52-week low/high is $1.026/$3.135.

Recent News


The QualityStocks Daily Newsletter would like to spotlightFathom SOBRsafe Inc. (NASDAQ: SOBR).

SOBRsafe Inc. (NASDAQ: SOBR) is a provider of a game-changing transdermal (touch-based) alcohol detection technology that can improve workplace safety and provides advanced screening and monitoring solutions for the behavioral health industry.

Alcohol misuse is the fourth leading cause of preventable death in the U.S., and the seventh worldwide. Nearly half of all industrial accidents with injuries are alcohol-related, and 1-in-10 U.S. commercial drivers tests positive for alcohol – the highest rate in the world. Despite these statistics, prevention and monitoring solutions have not kept pace with this epidemic. Legacy detection technologies are invasive and inefficient, unhygienic and unconnected. SOBRsafe believes there is a better way.

The company has developed a patent-pending alcohol detection device called SOBRcheck™ for use in detecting alcohol in humans, with just the touch of a finger. SOBRsafe’s next-generation transdermal technology detects and instantaneously reports the presence of alcohol as emitted through a user’s skin. No breath, blood or urine sample is required. SOBRsafe believes its technology is a superior, hygienic alternative to traditional breathalyzers for frontline, preventative applications.

With a powerful backend data platform, SOBRsafe provides humane, passive and connected alcohol detection for the behavioral health, transportation, oil and gas, judicial and consumer markets.

A preventative solution in historically reactive industries, SOBRsafe technology is being deployed for commercial fleets, workplaces, alcohol rehabilitation, probation management and teen drivers. This monitoring technology helps prevent intoxicated workers from taking the factory floor or drivers from receiving the keys to a truck, bus or family car. An offender is immediately flagged, and an administrator is empowered to take the appropriate corrective actions.

SOBRsafe technology is commercially available for access control (SOBRcheck), wearable use (SOBRsure™) and licensing or white labeling.

The company is headquartered in the Denver (CO) Technology Center.


The SOBRsafe technology is integrated within the company’s robust and scalable data platform, producing statistical and measurable user and business data.


With a mission is to save lives, increase productivity, create significant economic benefits and positively impact behavior, SOBRsafe developed the scalable, patent-pending SOBRsafe™ platform for non-invasive alcohol detection, real-time reporting and historical data aggregation.

SOBRsafe is a solution that has broad applications in behavioral health, fleet and facility safety, youth drivers and judicial markets.


SOBRcheck is the company’s stationary identification and alcohol monitoring product, providing a quick, specific-point-in-time test for the presence of alcohol. In hygienic, real-time fashion, SOBRcheck verifies user identity and determines the absence or presence of alcohol.

SOBRcheck provides an administrator immediate results – delivered securely – to aid in the efficient management of an existing substance abuse policy.


SOBRsure is the company’s transdermal, alcohol-detecting wearable. SOBRsure provides continuous, mobile alcohol monitoring. The band’s advanced alcohol safety technology discreetly detects and instantaneously reports the presence of alcohol in the body. Additionally, SOBRsure provides app-based alcohol detection alerts, pinpoint location tracking and band-removal notifications.

The SOBRcheck and SOBRsure revenue models consist of two components: (1) a hardware device purchase and (2) a recurring monthly SaaS subscription fee.

Design, manufacturing, quality testing and distribution for all SOBRsafe devices takes place in the U.S.


Market Opportunity

A report from Data Bridge Market Research, an international market research and consulting firm, estimated the global alcohol sensor market at $2.3 billion in 2022. The market is forecast to reach a value of $6.3 billion by 2030, recording a CAGR of 13.7% over the forecast period.

Market growth drivers, as cited by the report, include rising alcohol consumption rates, more stringent laws pertaining to alcohol consumption and new, more effective technologies that facilitate detection and enforcement.

Greater awareness of alcohol consumption as a potential threat to public and workplace safety has led to increased emphasis on preventing operation of motor vehicles and machinery by those under the influence of alcohol and promoting responsible alcohol consumption, as the report details.

Management Team

David Gandini is Chairman and CEO of SOBRsafe. He most recently served as president of IPS Denver, a bank card personalization company. Prior to that, Dave was the COO at First World Communications, a U.S. internet and data center provider, and participated in its successful IPO. He previously founded Pace Network Services and facilitated a successful exit to ICG Communications. Dave also co-founded Detroit-based Digital Signal in the fiber optic long haul market sector, where he executed a successful exit to SP Telecom.

Chris Whitaker, CPA, is CFO of SOBRsafe. Previously, Chris had served as the Company’s Vice President of Finance and Accounting. He has held various executive finance positions with large public multi-national corporations and small entrepreneurial companies throughout a progressive 30-year career that began with KPMG. Chris was formerly President – Americas and Vice President of Finance and Administration for public, multinational corporation Elixinol. He also served as the Managing Director of AEGIS Financial Consulting, leading a team of consultants in providing fractional CFO and financial consulting services to a wide variety of businesses in the public and private sectors.

Scott Bennett is EVP, Business Operations at SOBRsafe. He has more than 20 years of experience as a senior executive in technology-driven enterprises. Prior to joining SOBRsafe, he co-founded cybersecurity firm GBprotect and served as its COO until its successful sale to Nuspire. He previously served as Chief Technical Officer/Chief Information Security Officer of fintech businesses Catalyst Card Company and Integrated Printing Solutions.

SOBRsafe Inc. (NASDAQ: SOBR), closed Friday's trading session at $0.3888, off by 0.333248%, on 45,666 volume. The average volume for the last 3 months is 81,898 and the stock's 52-week low/high is $0.2004/$3.16.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.